Summary This global economic modeling study evaluated 50 years (1974–2024) of the WHO Expanded Programme on Immunization (EPI) across 194 WHO member states and 14 pathogens, using a societal-perspective cost model and...
1. MF59-aQIV looks economically persuasive in Korea and Taiwan — but the price assumptions do a lot of the work This modelling study assessed the cost-effectiveness of MF59-adjuvanted quadrivalent influenza vaccine...